Point of Care Lung CT for Patients with Acute Respiratory Failure

急性呼吸衰竭患者的护理点肺部 CT

基本信息

  • 批准号:
    10257985
  • 负责人:
  • 金额:
    $ 25.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-17 至 2022-02-28
  • 项目状态:
    已结题

项目摘要

Abstract Point of Care Lung CT for patients with Acute Respiratory Failure Two million patients develop acute respiratory failure requiring hospitalization in the US each year, with half requiring mechanical ventilation and more than 20% dying before discharge. Identifying underlying pulmonary pathologies in these patients is essential to ensuring they receive the right treatment, but standard chest imaging, a portable chest X-ray exam, poorly discriminates important pulmonary pathology in patients receiving invasive mechanical ventilation. Computed Tomography (CT) can identify pneumonia, pleural effusion, and/or pulmonary embolism (with contrast load) that may otherwise go undetected. Yet the risks and burden of moving critically ill patients to a conventional CT scanner is a significant barrier to safely performing CT in this population. A “point-of-care” CT scanner in the intensive care unit (ICU) would transform how care is provided to these patients. However, a portable device that is compact and low radiation yet capable of thoracic CT imaging does not currently exist. In this SBIR Phase II project, Xoran intends to develop and clinically validate a compact, mobile yet highly functional system to provide point of care thoracic CT images suitable for use in hospital ICUs and also deployable to field hospitals or other frontline settings. This effort builds on a previously commercialized compact and portable flat-panel CT technology for cranial applications, and leverages significant progress made in imaging capabilities for soft tissue structures in the brain and a prototype portable and compact open gantry mechanism intended for spine imaging. The project includes expansion of imaging capabilities using larger format detectors operating at fast frame rates in order to capture the larger volume of the lungs within the constraints of a patients breathing cycle. Self-shielding and self-disinfecting features will be incorporated to maximize safety and optimize workflows. Clinical evaluation will take place at the University of Michigan. Partnering with a team of Pulmonary and Critical Care physicians, thoracic radiology, and ICU nursing leadership, it will then establish the safety and clinical utility of point-of-care Thoracic CT system in support of FDA 510k submission leading to an approved indication for use and commercially viable product.
摘要 急性呼吸衰竭患者的床旁肺部CT 在美国,每年有200万患者发生急性呼吸衰竭, 其中一半需要机械通气,超过20%在出院前死亡。 确定这些患者的潜在肺部病变对于确保他们 接受正确的治疗,但标准的胸部成像,便携式胸部X光检查, 在接受有创机械通气的患者中区分重要的肺部病理 通风.计算机断层扫描(CT)可以识别肺炎、胸腔积液和/或 肺栓塞(造影剂负荷),否则可能无法检测到。然而,风险和 将危重患者转移到常规CT扫描仪的负担是 在这个人群中安全地进行CT。重症监护室中的“床旁”CT扫描仪 (ICU)将改变为这些病人提供护理的方式。然而, 目前还不存在紧凑和低辐射但能够进行胸部CT成像的设备。 在这个SBIR第二阶段项目中,Xoran打算开发一种紧凑的、移动的 然而,高功能的系统,以提供床旁胸部CT图像,适用于 医院ICU,也可部署到野战医院或其他前线环境。这种努力建立了 基于先前商业化的紧凑型便携式平板CT技术, 应用,并利用软组织成像能力方面取得的重大进展 结构和原型便携式和紧凑的开放式龙门机构, 用于脊柱成像。该项目包括使用更大格式扩展成像功能 以快速帧速率操作的检测器,以便捕获肺内的较大体积 患者呼吸周期的限制。自屏蔽和自消毒功能将 以最大限度地提高安全性和优化工作流程。临床评价将在 密歇根大学与肺科和重症监护医生团队合作, 胸放射科和ICU护理领导,然后将建立安全性和临床实用性 床旁胸部CT系统,以支持FDA 510 k提交,从而获得批准 适应症和商业上可行产品。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Charles VanKampen其他文献

William Charles VanKampen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Charles VanKampen', 18)}}的其他基金

Point of Care Lung CT for Patients with Acute Respiratory Failure
急性呼吸衰竭患者的护理点肺部 CT
  • 批准号:
    10518890
  • 财政年份:
    2021
  • 资助金额:
    $ 25.21万
  • 项目类别:
Point of Care Lung CT for Patients with Acute Respiratory Failure
急性呼吸衰竭患者的护理点肺部 CT
  • 批准号:
    10632085
  • 财政年份:
    2021
  • 资助金额:
    $ 25.21万
  • 项目类别:
An Integrated CT-based Image-Guided Neurosurgical System
基于 CT 的集成图像引导神经外科系统
  • 批准号:
    10017876
  • 财政年份:
    2005
  • 资助金额:
    $ 25.21万
  • 项目类别:
An Integrated CT-based Image-Guided Neurosurgical System
基于 CT 的集成图像引导神经外科系统
  • 批准号:
    8833522
  • 财政年份:
    2005
  • 资助金额:
    $ 25.21万
  • 项目类别:
An Integrated CT-based Image-Guided Neurosurgical System
基于 CT 的集成图像引导神经外科系统
  • 批准号:
    10242118
  • 财政年份:
    2005
  • 资助金额:
    $ 25.21万
  • 项目类别:
An Integrated CT-based Image-Guided Neurosurgical System
基于 CT 的集成图像引导神经外科系统
  • 批准号:
    9764897
  • 财政年份:
    2005
  • 资助金额:
    $ 25.21万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 25.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了